Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 799 Precursor Cell Lymphoblastic Leukemia-Lymphoma 169 Recurrence 140 Neoplasms, Plasma Cell 110 Lymphoma 93 Leukemia 91 Neoplasms 81 Burkitt Lymphoma 57 Vomiting 51 Lymphoma, Non-Hodgkin 50 Immunoglobulin Light-chain Amyloidosis 49 Lymphoma, Large B-Cell, Diffuse 44 Nausea 38 Lymphoma, Mantle-Cell 38 Prostatic Neoplasms 31 Lymphoma, Follicular 30 Hodgkin Disease 29 Waldenstrom Macroglobulinemia 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 27 Neoplasm Metastasis 26 Leukemia, Lymphocytic, Chronic, B-Cell 26 Carcinoma, Non-Small-Cell Lung 26 Leukemia, Myeloid, Acute 25 Breast Neoplasms 25 Lung Neoplasms 22 Amyloidosis 21 Leukemia, Biphenotypic, Acute 18 Lymphoma, B-Cell, Marginal Zone 17 Lymphoma, Extranodal NK-T-Cell 16 Smoldering Multiple Myeloma 15

Interventions

enzalutamide 7 Prednisone 7 cabazitaxel 6 Radiosurgery 6 Docetaxel 5 Androgen Antagonists 4 Abiraterone Acetate 4 XRP6258 2 Standard of Care 2 talazoparib 1 sipuleucel-T 1 rucaparib 1 pembrolizumab 1 olaparib 1 gallium 68 PSMA-11 1 fludrocortisone acetate 1 darolutamide 1 apalutamide 1 Zuclomiphene 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisolone 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Midazolam 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 LY3023414 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prostate Cancer Metastatic × Dexamethasone × Clear all

NCT06136624 2026-05-05

OMAHA-003

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡